These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8185369)
41. A report of two cases of Kawasaki disease treated with plasma exchange. Harada T; Ito S; Shiga K; Inaba A; Machida H; Aihara Y; Yokota S Ther Apher Dial; 2008 Apr; 12(2):176-9. PubMed ID: 18387169 [TBL] [Abstract][Full Text] [Related]
42. C1q nephropathy: a case with severe atopic dermatitis. Ekim M; Ikinciogullari A; Berberoglu M; Tulunay O; Sencer H; Ozkaya N; Reisli I; Tumer N Pediatr Nephrol; 2002 Jul; 17(7):547-9. PubMed ID: 12172773 [TBL] [Abstract][Full Text] [Related]
43. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Eden OB; Lilleyman JS Arch Dis Child; 1992 Aug; 67(8):1056-8. PubMed ID: 1520013 [No Abstract] [Full Text] [Related]
44. Intravenous immunoglobulin or megadose methylprednisolone for the treatment of idiopathic thrombocytopenic purpura. Ozsoylu S Am J Pediatr Hematol Oncol; 1991; 13(3):364-5. PubMed ID: 1817495 [No Abstract] [Full Text] [Related]
45. Child with atopic dermatitis. Kanchongkittiphon W; Gaffin JM; Phipatanakul W Ann Allergy Asthma Immunol; 2015 Jan; 114(1):6-11. PubMed ID: 25528736 [No Abstract] [Full Text] [Related]
46. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens]. Silny W; Czarnecka-Operacz M; Silny P Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162 [TBL] [Abstract][Full Text] [Related]
47. [Present status of high-dose intravenous immunoglobulin therapy and the future prospects ]. Kawasugi K Nihon Rinsho Meneki Gakkai Kaishi; 2003 Jun; 26(3):87-95. PubMed ID: 12868126 [No Abstract] [Full Text] [Related]
48. [Kawasaki disease--two case reports]. Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293 [TBL] [Abstract][Full Text] [Related]
49. Clinical features of atypical Kawasaki disease. Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122 [TBL] [Abstract][Full Text] [Related]
50. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. Jolles S; Sewell C; Webster D; Ryan A; Heelan B; Waite A; Rustin M Acta Derm Venereol; 2003; 83(6):433-7. PubMed ID: 14690338 [TBL] [Abstract][Full Text] [Related]
53. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. Law C; Marcaccio M; Tam P; Heddle N; Kelton JG N Engl J Med; 1997 May; 336(21):1494-8. PubMed ID: 9154768 [TBL] [Abstract][Full Text] [Related]
54. Changes in cardiac troponin I in Kawasaki disease before and after treatment with intravenous gammaglobulin. Kim M; Kim K Jpn Circ J; 1998 Jul; 62(7):479-82. PubMed ID: 9707002 [TBL] [Abstract][Full Text] [Related]
55. Use of intravenous gammaglobulin as an immune replacement and an immune suppressant. Boshkov LK; Kelton JG Transfus Med Rev; 1989 Apr; 3(2):82-120. PubMed ID: 2520551 [No Abstract] [Full Text] [Related]
56. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. Arkwright PD; David TJ J Allergy Clin Immunol; 2001 Mar; 107(3):531-4. PubMed ID: 11240956 [TBL] [Abstract][Full Text] [Related]
57. Intravenous immunoglobulin to treat severe atopic dermatitis in children: a case series. Turner PJ; Kakakios A; Wong LC; Wong M; Campbell DE Pediatr Dermatol; 2012; 29(2):177-81. PubMed ID: 22085141 [TBL] [Abstract][Full Text] [Related]